RET荧光原位杂交是敏感但高度非特异的肺癌RET融合筛查方法
RNA NGS组2015例中14例RET融合,双检9例FISH均重排。WGS显示RET功能性融合占所有破坏性事件比例(4/9,44%)低于ALK(27/34,79%)和ROS1(9/12,75%)。结论为FISH敏感但非特异,需正交技术确认。
要点
- FISH筛查RET重排阳性者中仅部分为功能性融合,需NGS确认。
- RET功能性融合占破坏性事件比例低于ALK和ROS1位点。
- FISH检测RET融合敏感但非特异,不宜单独用于治疗选择。
核心结论
- FISH是敏感但非特异的RET融合筛查方法,因常见RET重排不产生功能性融合,始终需要正交技术确认。
研究设计与样本
- 阳性且材料充足者行双方法检测(n=39)及多种FISH检测(n=17)。
- 独立队列520例NSCLC患者行全基因组测序,分析RET、ALK和ROS1位点的破坏性结构变异与功能性融合。
主要发现
- FISH分析2858例中48例RET重排,双检NGS的30例中仅9例为功能性RET融合。
- RNA NGS检测2015例中14例RET融合,双检FISH的9例均显示RET位点重排。
- 18例验证的RET融合中,FISH显示16例分裂信号、2例复杂重排。
- 全基因组测序显示功能性融合占所有破坏性事件比例:RET为4/9(44%),ALK为27/34(79%),ROS1为9/12(75%)。
临床怎么用
- FISH检测RET重排阳性后,应使用RNA NGS等正交技术确认功能性融合,再指导治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: RET gene fusions are established oncogenic drivers in 1% of NSCLC. Accurate detection of advanced patients with RET fusions is essential to ensure optimal therapy choice. We investigated the performance of fluorescence in situ hybridization (FISH) as a diagnostic test for detecting functional RET fusions. METHODS: Between January 2016 and November 2019, a total of 4873 patients with NSCLC were routinely screened for RET fusions using either FISH (n = 2858) or targeted RNA next-generation sequencing (NGS) (n = 2015). If sufficient material was available, positive cases were analyzed by both methods (n = 39) and multiple FISH assays (n = 17). In an independent cohort of 520 patients with NSCLC, whole-genome sequencing data were investigated for disruptive structural variations and functional fusions in the RET and compared with ALK and ROS1 loci. RESULTS: FISH analysis revealed RET rearrangement in 48 of 2858 cases; of 30 rearranged cases double tested with NGS, only nine had a functional RET fusion. RNA NGS yielded RET fusions in 14 of 2015 cases; all nine cases double tested by FISH had RET locus rearrangement. Of these 18 verified RET fusion cases, 16 had a split signal and two a complex rearrangement by FISH. By whole-genome sequencing, the prevalence of functional fusions compared with all disruptive events was lower in the RET (4 of 9, 44%) than the ALK (27 of 34, 79%) and ROS1 (9 of 12, 75%) loci. CONCLUSIONS: FISH is a sensitive but unspecific technique for RET screening, always requiring a confirmation using an orthogonal technique, owing to frequently occurring RET rearrangements not resulting in functional fusions in NSCLC.
引用
- Radonic T, Geurts-Giele WRR, Samsom KG, et al. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer. J Thorac Oncol. 2021. PMID: 33588111. doi:10.1016/j.jtho.2021.01.1619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。